Advanced Cell Technology, Inc. (OTC:ACTC) is moving up again. Yesterday, the stock soared the next 7.93%, while trading 
over 6 million shares on the market.
Of course, the reason for the climb is crystal clear – another stock alert about ACT. It came up just yesterday, when seekingalpha.com discussed some pros and cons related to the company’s business.
Despite the fact that a number of risk factors were featured in the article, it certainly attracted attention and pushed up the stock price. Though, the publication was named The Dream Team Of Speculative Biopharm, which investors should carefully consider.
Apart from the news that ACT will be presenting at two upcoming conferences, no other updates on the company were published these days. As recently mentioned on hotstocked.com, while being silent, trading activity around the shares of ACT common stock got much higher. [BANNER]
In August, some of the company’s chief officers bought a huge part of its shares with no particular reason. Meanwhile, ACT filed with the SEC some documents full of risk factors and uncertainties about its business.
At the same time, apparently the company’s financials haven’t improved yet, and the numerous conditions remain the biggest issue for ACT.
